Chao Zhang

ORCID: 0000-0002-5957-2287 · 14 papers in corpus
review 2024
European journal of medical research ·doi:10.1186/s40001-024-02236-1

Alarmins are a class of molecules released when affected cells damaged or undergo apoptosis. They contain various chemotactic and immunomodulatory proteins or peptides. These molecules regulate the immune response by interacting with patter…

other 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1428147

BACKGROUND: Amphiregulin (AR) is a growth factor that resembles the epidermal growth factor (EGF) and serves various functions in different cells. However, no systematic studies or reports on the role of AR in human oocytes have currently b…

observational 2024
Frontiers in oncology ·doi:10.3389/fonc.2024.1495753

INTRODUCTION: Primary cilia play an important role in the development of cancer by regulating signaling pathways. Several studies have demonstrated that women with BRCA mutations have, on average, 50% fewer ciliated cells compared with gene…

observational 2023
Ultrasound quarterly ·doi:10.1097/ruq.0000000000000661

Transvaginal 4-D hysterosalpingo-contrast sonography (TV 4-D HyCoSy) plays an important role in the detection and diagnosis of clinical female infertility. The purposes of this study were to analyze the influencing factors of TV 4murD HyCoS…

other 2023
PeerJ ·doi:10.7717/peerj.14653

Ovarian clear cell carcinoma (OCCC) is a special histological type of epithelial ovarian cancer (EOC) that is not derived from epithelial cells of the ovarian or fallopian tube as the most common type of ovarian cancer, high-grade serous ov…

observational 2022
·doi:10.21203/rs.3.rs-2128626/v2

Abstract Objective To investigate the expression of nuclear actor-k-gene binding(NF-κB) and immediate early response 3(IER3) in nuclear factor-activated B cells in ovarian endometrioid cysts. To analyze the correlation between the express…

2022
·doi:10.21203/rs.3.rs-2128626/v1
other 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.1003605

OBJECTIVE: To study specific information on trends in incidence, mortality, disability-adjusted life years (DALY) and the corresponding trends among five sociodemographic index regions, 21 regions, and 204 countries for decision-making, whi…

lab-animal 2022
BMC pharmacology & toxicology ·doi:10.1186/s40360-022-00573-7

INTRODUCTION: Nalbuphine can relieve patients' inflammation response after surgery compared to other opioid drugs. However, its molecular mechanism has not been clear. Activation of NF-κB signaling pathway under oxidative stress and inflamm…

lab-animal 2020
Journal of ethnopharmacology ·doi:10.1016/j.jep.2020.113051

ETHNOPHARMACOLOGICAL RELEVANCE: Ermiao fang (EMF) is a traditional Chinese medicinal herbal formula from ancient times and recorded in the pharmacopeia of the People's Republic of China. It is composed of two typical Chinese herbal medicine…

lab-animal 2019
Frontiers in pharmacology ·doi:10.3389/fphar.2019.00764

Tussilagone (TSL) is a sesquiterpenoid isolated from Tussilago farfara, which has been used as a traditional medicine for the treatment of asthma and bronchitis. It also takes part in the anti-inflammatory and antioxidant effects, but its r…

lab-animal 2010
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences ·doi:10.1016/j.ejps.2010.01.012

The objective of this study was to prepare a novel mifepristone-loaded PCL/Pluronic F68 implant to achieve long-term treatment of endometriosis. PCL/Pluronic F68 compound (90/10, w/w) with viscosity average molecular weight of 65,000 was su…

observational 2007
Zhonghua fu chan ke za zhi

OBJECTIVE: To analyze the recurrence and fertility outcome of stage III - IV endometriosis after conservative surgery. METHODS: A retrospective study was performed on 90 women with stage III - IV endometriosis who had been diagnosed by pat…

observational 2007
·doi:10.3760/j.issn:0529-567x.2007.02.006

目的 探讨Ⅲ~Ⅳ期子宫内膜异位症患者保守性手术后的复发和妊娠结局.方法 回顾性分析90例Ⅲ~Ⅳ期子宫内膜异位症患者的临床资料,均行保留子宫和部分卵巢的保守性手术.16例患者单纯行保守性手术(术后未用药,A组),52例术后予孕三烯酮治疗(B组),22例术后予促性腺激素释放激素激动剂(GnRHa)治疗(C组).3组中不孕症患者分别是10、15和10例.随访24~84个月(中位时间是48.5个月),比较3组患者的术后复发、妊娠情况及妊娠结局.结果 A、B、C 3组的复发率分别是18…